Mersana Therapeutics
MRSN
MRSN
50 hedge funds and large institutions have $283M invested in Mersana Therapeutics in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.05% less ownership
Funds ownership: 3.08% → 3.03% (-0.05%)
6% less capital invested
Capital invested by funds: $302M → $283M (-$19M)
Holders
50
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$7.78M | |
| 2 | +$6.93M | |
| 3 | +$5.15M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$442K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$376K |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$955K | |
| 3 | -$865K | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$346K |
| 5 |
Citigroup
New York
|
-$277K |